Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Grows By 159.3%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 166,500 shares, an increase of 159.3% from the February 26th total of 64,199 shares. Based on an average daily trading volume, of 368,096 shares, the days-to-cover ratio is currently 0.5 days.

MediPharm Labs Price Performance

MediPharm Labs stock traded up $0.00 during trading on Friday, reaching $0.05. The company had a trading volume of 55,259 shares, compared to its average volume of 98,521. The firm’s 50-day simple moving average is $0.05 and its 200 day simple moving average is $0.05. MediPharm Labs has a 1-year low of $0.04 and a 1-year high of $0.08.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.